Biomarker-Guided Anti-inflammatory Therapies: From Promise to Reality Check

JAMA Psychiatry. 2019 Aug 1;76(8):779-780. doi: 10.1001/jamapsychiatry.2019.0673.

Authors

Michael Berk^{1

2}, Adam J Walker¹, Andrew A Nierenberg³

Affiliations

¹ Deakin University, IMPACT Strategic Research Centre, Geelong, Victoria, Australia.
² Orygen, The National Centre of Excellence in Youth Mental Health, Department of Psychiatry, the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia.
³ Massachusetts General Hospital and Harvard Medical School, Boston.

PMID: 31066892
DOI: 10.1001/jamapsychiatry.2019.0673

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Adult
Anti-Inflammatory Agents
Biomarkers
Bipolar Disorder*
Depression
Humans
Infliximab

Substances

Anti-Inflammatory Agents
Biomarkers
Infliximab